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Shiga toxin (Stx)-producing Escherichia coli (STEC) are pathogenic E. coli causing diarrhea,
hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS). STEC are characterized
by a constellation of virulence factors additional to Stx and have long been regarded as
capable to cause HC and HUS when possessing the ability of inducing the attaching
and effacing (A/E) lesion to the enterocyte, although strains isolated from such severe
infections sometimes lack this virulence feature. Interestingly, the capability to cause
the A/E lesion is shared with another E. coli pathogroup, the Enteropathogenic E. coli
(EPEC). In the very recent times, a different type of STEC broke the scene causing a
shift in the paradigm for HUS-associated STEC. In 2011, a STEC O104:H4 caused a large
outbreak with more than 800 HUS and 50 deaths. Such a strain presented the adhesion
determinants of Enteroaggregative E. coli (EAggEC). We investigated the possibility that,
besides STEC and EAggEC, other pathogenic E. coli could be susceptible to infection with
stx-phages. A panel of stx2-phages obtained from STEC isolated from human disease
was used to infect experimentally E. coli strains representing all the known pathogenic
types, including both diarrheagenic E. coli (DEC) and extra-intestinal pathogenic E. coli
(ExPEC). We observed that all the E. coli pathogroups used in the infection experiments
were susceptible to the infection. Our results suggest that the stx2-phages used may not
have specificity for E. coli adapted to the intestinal environment, at least in the conditions
used. Additionally, we could only observe transient lysogens suggesting that the event of
stable stx2-phage acquisition occurs rarely.
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INTRODUCTION
The ability to produce Shiga toxins (Stx) is the major virulence
feature of Shiga toxin-producing Escherichia coli (STEC). These
potent cytotoxins block the protein synthesis by inactivating ribo-
somes (Okuda et al., 2006) and their action on the target cells is
responsible for the most severe forms of STEC-induced disease,
such as hemorrhagic colitis and the life-threatening hemolytic
uremic syndrome (HUS) (Karmali, 2009). The Stx-coding genes,
stx, are conveyed by lambdoid bacteriophages (O’brien et al.,
1984), which, following infection of a susceptible E. coli strain,
are maintained into a lysogenic state in the host chromosome,
becoming a virulence marker for STEC. In spite of the striking
effect exerted by Stx on susceptible cells, their sole production
seems to be not sufficient for STEC to induce severe disease in
humans. In fact, STEC associated with HUS usually colonize the
gastrointestinal tract of the host by inducing a typical lesion to
the enterocyte known as attaching and effacing (A/E) (Mcdaniel
and Kaper, 1997). Noteworthy, the ability to induce the A/E lesion
is shared with Enteropathogenic E. coli (EPEC), another E. coli
pathogroup historically causing outbreaks of infection with high
mortality rates in Europe and US up to the end of the second
World War, and nowadays representing a leading cause of diar-
rhea and infantmortality in the developing countries (Tozzoli and
Scheutz, 2014). Until recently this combination of virulence traits,
the ability to produce Stx and to cause the A/E lesion, represented
the paradigm for HUS-associated STEC, altogether defined as
Enterohaemorrhagic E. coli (EHEC) (Levine, 1987).
In 2011, in Germany, an outbreak of STEC infections occurred
that caused more than 4000 infections, including 900 HUS cases
and 50 deaths (Bielaszewska et al., 2011). The outbreak strain,
beside the production of Stx, possessed the intestinal coloniza-
tion apparatus typical of another E. coli pathogroup, known as
Enteroaggregative E. coli (EAggEC). As a matter of fact, the out-
break strain possessed the adhesion-associated genes typical of
EAggEC such as aggR, aaiC, sepA, aatA (Schmidt et al., 1995;
Boisen et al., 2008, 2012) and, at the same time, it carried a bac-
teriophage conveying the genes encoding the Shiga toxin type 2
subtype a (stx2a) (Bielaszewska et al., 2011; Scheutz et al., 2011).
The impact of the German outbreak was so deep that
the causative STEC strain became iconic of a new E. coli
pathotype: the Enteroaggregative Hemorrhagic E. coli (EAHEC)
(Brzuszkiewicz et al., 2011). It has to be noted that E. coli strains
matching the virulence genes profile of the EAHEC O104:H4 had
been previously observed in a few occasions. At the beginning
of the 90s, a small HUS outbreak occurred in France (Morabito
et al., 1998). The episode was associated to infection with an E. coli
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O111:H2 strain possessing the ability to colonize the host gut by
the staked-brick adhesion mechanism typical of EAggEC (Nataro
and Kaper, 1998) but which was also able to elaborate Stx2
(Morabito et al., 1998). Additionally, after the German outbreak
caused by EAHECO104:H4, a few sporadic cases of infection with
similar EAHEC strains were retrospectively described in the time
period 2000–2010 (Iyoda et al., 2000; Scavia et al., 2011). Finally,
an HUS case, associated with EAHEC O111:H21 and an outbreak
of EAHEC O127:H4 infections occurred, in Northern Ireland in
2012 (Dallman et al., 2012) and in Italy in 2013 (unpublished),
respectively.
Up to the present day, four different EAHEC serotypes have
been therefore identified including the O111:H2 (Morabito et al.,
1998), O104:H4 (Bielaszewska et al., 2011), O111:H21 (Dallman
et al., 2012), and O127:H4. This observation, together with the
reported isolation of Enterobacteriaceae other than E. coli pro-
ducing Stx from cases of human disease (Tschape et al., 1995;
Paton and Paton, 1996) suggests that stx-phages can infect a
range of bacterial hosts wider than expected. Further evidences
supporting this hypothesis had been provided by Schmidt and
co-workers, who were able to infect and lysogenize different
E. coli pathogroups including EPEC, STEC, EAggEC, and EIEC
using a chloramphenicol-resistant derivative of an Stx2-encoding
Bacteriophage (Schmidt et al., 1999).
Recently the susceptibility of EAggEC strains of different
serotypes to infection with the stx2-phage P13374 obtained
from the German EAHEC O104:H4 strain has been investigated
(Beutin et al., 2012). In that study, however, all the strains tested
were found to be resistant to a high infective dose of P13374 and
the authors concluded that the phage used had a restricted host
range among EAggEC.
In order to contribute additional evidences to the subject mat-
ter, we investigated the ability of a panel of six stx2-phages to
infect and lysogenize E. coli strains belonging to all the know
pathogroups, including both diarrheagenic (DEC) and extrain-
testinal pathogenic E. coli (ExPEC). We describe that, at least in
the conditions used in the laboratory, all the phages used were
able to infect some of the strains belonging to all the E. coli
pathogroups. Additionally, one of the phages used was able to
produce lysogens visible after one cultural passage, which were
no longer observable at the following passage.
Our observations suggest that the stx-phages used have a broad
host specificity toward different E. coli pathogroups but that their
stable acquisition might be a rare event.
MATERIALS AND METHODS
BACTERIAL STRAINS AND stx2-PHAGES
All the strains used in the present study are part of the col-
lections held at Istituto Superiore di Sanità. A total of 33 E.
coli strains were used as recipients for infection experiments. In
detail, five typical Enteropathogenic E. coli (tEPEC), five atypical
EPEC strains (aEPEC), five Enteroaggregative E. coli (EAggEC),
five Enterotoxigenic E. coli (ETEC), three Enteroinvasive E. coli
(EIEC), five Extraintestinal Pathogenic E. coli (ExPEC) strains iso-
lated from urinary tract infections and five non-pathogenic E. coli
strains from the ECOR collection (Ochman and Selander, 1984)
were infected with stx2-phages. Typical and atypical EPEC were
positive to PCR specific for the intimin-coding eae gene (Oswald
et al., 2000). All typical EPEC also possessed the EAF plasmid as
assessed by PCR of the BfP-coding gene (Franke et al., 1994).
All the EAggEC possessed the aat (Schmidt et al., 1995), aggR
and aaiC (Boisen et al., 2012) genes as assessed by PCR in the
conditions described in the respective papers.
PCR amplification was also used to identify the presence of the
heat-stable (ST) and heat-labile (LT) enterotoxins coding-genes
(Liu et al., 2013), ipaH (Liu et al., 2013) and the genes encoding
the cytotoxic-necrotizing factor (CNF) (Kadhum et al., 2006) to
verify the pathogroups ETEC, EIEC and ExPEC, respectively, in
the conditions indicated in the respective papers.
E. coli K12 strains LE392 and DH5α have been used as con-
trol strains in infection experiments and for the stx2-phages
amplification.
The E. coli strains CB553/5 and C125-06 (courtesy of Dr.
Flemming Scheutz) and ED 191, ED 924, ED 703 and ED 508,
were used to obtain the stx2-phages used for the infections by the
spot agar assays. The CB553/5 strain is an ETEC O166:H15 pos-
sessing both stx2 and LT genes and isolated from a human case
of non-complicated diarrhea in Denmark. Strain C125-06 is a
STEC O103:H25 isolated during a large HUS outbreak occurred
in Norway in 2006 (Schimmer et al., 2008), possessing an stx2-
phage with the gene encoding the Stx2 B subunit interrupted by
an IS1203 (this study, data not shown), which doesn’t produce
an active Shiga toxin. Strains ED 191 (O111:H2) and ED 924
(O127:H4) are Enteroaggregative-Hemorrhagic E. coli (EAHEC)
strains isolated from small HUS outbreaks occurred in France
in 1992 (Morabito et al., 1998) and in Northern Italy in 2013
(unpublished), respectively. Strain ED 703 is an O104:H4 EAHEC
isolated from a HUS case occurred in Italy in 2009 (Scavia et al.,
2011). Strain ED 508 is a STEC O157 producing Stx2 and isolated
in Italy from a human case of disease. The stx2-phages derived
from these E. coli strains have been termed with the strain’s name
preceded by the prefix Phi (e.g., Phi-508 from strain ED 508).
The panel of six Stx2-converting phages used to set up the
infection experiments was selected using as a criterion their asso-
ciation with STEC of public health relevance. As a matter of
fact, all the stx-phages conveyed the Stx2-coding genes, the toxin
type associated with the most severe forms of STEC infections.
Additionally, phages conveying such Stx type are the only ones
so far associated with E. coli pathogroups other than the classical
STEC.
PHAGES INDUCTION AND AMPLIFICATION
The E. coli strains carrying the stx2-phages were exposed to UV
light in order to induce the excision of the phage genome from the
bacterial chromosome (Sambrook and Russell, 2001). In detail,
each bacterial strain was grown in Luria-Bertrani (LB) broth
(Oxoid Limited, Basingstoke Hampshire, UK) overnight at 37◦C
with vigorous shaking. The culture was diluted 1:100 in LB mod-
ified broth (LB with 0.001% thiamine V/V) grown to 0.5 OD
600 and centrifuged. The bacterial pellets were re-suspended in
a sterile solution of CaCl2 10mM. The culture was exposed to
UV light (130μ Joule × 100) in a “Stratalinker® UV crosslinker”
(Stratagene Cloning Systems, La Jolla, CA, USA). After induc-
tion, the culture was diluted in LB modified broth and incubated
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at 37◦C for 5 h with vigorous shaking. The culture was cen-
trifuged and the supernatant containing phages particles filtered
with 0.45μm pore-filters. 100μl of phage particles suspension
were added to 100μl of a culture of the propagator strain E.
coli LE392 grown in LB modified broth at 0.5 OD 600 and the
resulting mixture was maintained at 37◦C for 20min with static
incubation. Each tube was added with 3.5ml of LB modified soft
agar (LB modified broth with agar 7 g/L) kept at 42◦C and imme-
diately poured on LB modified agar plates (LB modified broth
with agar 15 g/L). Plates were incubated overnight at 37◦C.
Four ml of SM buffer (100mM NaCl, 8mM MgSO4·7H2O,
50mM Tris-HCl 1M pH 7.5, Gelatin 0.002%) were dispensed
to each plate in order to recover phages particles from the lytic
plaques and kept overnight at 4◦C. The phage suspension in SM
was recovered and added with chloroform at 5% final concentra-
tion. The phage suspension has been centrifuged at 500× g 10min
twice for removing agar debris and used to re-infect the propaga-
tor E. coli strain LE392 in the conditions described above in order
to increase the phage titre. Finally, the phage suspension was con-
centrated by using Amicon Ultra-15 Centrifugal Filter Unit with
Ultracel-30 tubes (Merck Millipore, Billerica, MA, USA) with a
cut-off of 30 KDa. Final phage titres ranged from 1 × 1010 to
4.9 × 1011 PFU/ml.
DETERMINATION OF THE stx2-PHAGES INTEGRATION SITES IN THE
E. COLI GENOME
The stx2-phages integration sites in the E. coli strains were deter-
mined. The occupancy of loci sbcB, wrbA, yehV, and Z2577
was assessed as previously described (Serra-Moreno et al., 2007).
An additional primer pair (YecE_fwd GCTAGCGCCGAGCAGC
ACAA/YecE_rev ATGGCCGATGGCACCTGTCT) was deployed
for specifically investigating the integrity of the locus yecE (this
study).
SHIGATOXIN-GENES SUBTYPING
The determination of stx-genes subtypes was performed by PCR
as previously described (Scheutz et al., 2012).
PLAQUE LIFT AND HYBRIDIZATION
Plaque blot experiments were performed to assay the homogene-
ity of the phages suspensions (Sambrook and Russell, 2001). In
detail, phage induction experiments were performed as described
above. A nylon membrane (Hybond N+, GE Healthcare Life
Sciences, UK) was placed onto the surface of each agar plate con-
taining the phages plaques originated by lysis of the propagator
strain and kept in place for 5min. The filters were lifted from the
plates and incubated with denaturation buffer (1.5MNaCl, 0.5M
NaOH) at room temperature for 5min and dried on aWhatman®
paper 3mm (GEHealthcare Life Sciences, UK). Filters were trans-
ferred to a new Whatman® paper 3mm sheet impregnated with
neutralization buffer (0.5M Tris-Cl pH 7.2, 1M NaCl) for 5min.
The membranes were dried and incubated with SSC 2× (6M
NaCl and 0.6M sodium citrate) for 5min. Once dried, 1μl of
a positive control, made up by unlabeled DNA corresponding to
the probe used in the following hybridizations, was spotted on
each filter. DNA was fixed by UV light (1200μ Joule × 100) in
a crosslinker “Stratalinker® UV crosslinker” (Stratagene Cloning
Systems, La Jolla, CA, USA).
A DNA fragment obtained by PCR amplification of the
stx2-gene using the primers Stx2F/Stx2R (Paton and Paton,
2002) was labeled by incorporating the digoxygenin-11-deoxy-
uridine-triphosphate using the PCR DIG probe synthesis Kit
(Roche Diagnostics, Switzerland) and used as a probe. A pre-
hybridization step was performed incubating the membranes in a
buffer containing SSC 5×, 0.01% N-Lauryl Sarcosine, 1% block-
ing reagent (Roche Diagnostics, Switzerland) at 68◦C for 1 h. The
hybridization was carried out by incubating the filters overnight
with 500 ng of the labeled probe at 68◦C. The membranes were
washed in SSC 2× with 0.1% SDS two times with agitation for
5min followed by two washes in SSC 0.04× with 0.1% SDS
at 64◦C 15min. The detection of the hybridized Digoxygenin-
labeled probe was carried out with Anti- Digoxigenin AP
Fab fragments and the detection reagent NBT/BCIP solution
following the manufacturer’s instructions (Roche Diagnostics,
Switzerland).
INFECTION EXPERIMENTS BY SPOT AGAR ASSAY
The susceptibility of E. coli strains to the stx2-phages was assessed
by spot agar assay as described elsewhere (Muniesa et al., 2004).
In detail, each host strain was grown in LB medium overnight
with vigorous shaking, diluted 100 times in LB modified broth
(LB with 0.001% thiamine V/V) and grown at 0.5 OD 600. One
hundred μl of the culture were added with 4ml of LB modified
soft agar (LB modified broth with agar 7 g/L) at 42◦C and imme-
diately poured on LB modified agar plates (LB modified broth
with 15 g/L agar). Ten μl of each stx2-phage was spotted on each
recipient strain immediately after the solidification of the soft
agar layer. Phage titres used were: 1 × 1010 PFU/ml for the stx2-
phages Phi- C125-06, Phi-703 and Phi-191, 1.5 × 1010 PFU/ml
for Phi-CB553/5, 1.9 × 1010 PFU/ml for Phi-508 and 4.9 × 1011
for the stx2-phage from the EAHEC ED 924, Phi-924. Plates were
incubated overnight at 37◦C.
ASSESSMENT OF TOXIN PRODUCTION AND COLONY BLOT
In all the cases where lytic areas were not visible, the infection of
the recipient strains was verified by carrying out Vero cell assays
for the identification of the Stx production (Caprioli et al., 1994).
In detail, part of the top agar taken from the plates in
correspondence with the area where the stx2-phage suspen-
sion was applied during the spot agar assay, was incubated in
2ml of Tripticase Soya Broth (TSB, Oxoid Limited, Basingstoke
Hampshire, UK) overnight at 37◦C. One ml of the culture was
centrifuged at 13000×g 10min and the supernatant was filtered
with 0.45μm pore-filters. Twenty μl of each supernatant were
inoculated on a semi-confluent monolayer of Vero cells. The pres-
ence of cythopathic effect was assessed at 24 h and confirmed at
48 and 72 h.
The E. coli recipients infected with the stx2-phage Phi-C125-
06:IS1203, which does not induce the production of an active Stx,
were verified by colony blot. Scalar dilutions of the overnight cul-
tures obtained as described above were diluted and plated on LB
agar plates in way of having about 50 colonies on each of the
plates.
Bacterial colonies were transferred to a nylon membrane with
high affinity for nucleic acids (Hybond N+, GE Healthcare Life
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Sciences, UK) by keeping the filter in contact with the surface
of the agar for 5min. The filters were incubated with denatura-
tion buffer (1.5M NaCl, 0.5M NaOH) for 20min and dried on a
Whatman® paper 3mm (GEHealthcare Life Sciences, UK). A fur-
ther incubation on a Whatman® paper 3mm impregnated with a
buffer containing Triton X-100 0.2 % and NaOH 0.05 N was car-
ried out for 10min. Once dried, each filter was moved to a new
sheet of Whatman® paper 3mm impregnated with neutralization
buffer (0.5M Tris-Cl pH 7.2, 1M NaCl) and dried again. The
hybridization and detection steps were carried out as described
above in the section “Plaque Lift and Hybridization.”
RESULTS
CHARACTERIZATION OF THE stx2-PHAGES USED IN THE INFECTION
EXPERIMENTS
Although all the phages used in the infection experiments were
obtained from epidemiologically unrelated E. coli strains with dif-
ferent genomic background, including STEC, EAggEC and ETEC,
they have been partially characterized to ascertain that we were
not dealing with a homogeneous phage population made up by
identical phage types.
Recently a peculiar type of stx2-phage has been described as
being associated with STECO157 isolated from human infections
(Tozzoli et al., 2014). Such a phage, termed 8, presented large
genomic differences when compared to the sequence of the ref-
erence stx2-phage BP933W, present in the reference STEC O157
strain EDL933, in the regions where the Stx-coding genes are
located and containing the genes regulating the switch between
lysogeny and lytic cycle, respectively (Tozzoli et al., 2014). All the
phages in the panel used in the infection experiments were neg-
ative to a 8-specific PCR (Tozzoli et al., 2014) but the Phi-508
phage, indicating that only the latter belonged to this particular
phage type.
The whole genome sequences (WGS) of the strains CB553/5,
ED 508, ED 703 and ED 924 and of the phage Phi-191 from the
EAHEC O111:H2 that caused the outbreak in France in the 90s
have been determined (data not shown). The contigs composing
theWGS of the bacterial strains weremapped against the genomic
sequence of the phage Phi-191 (data not shown).
The comparison showed that in the genomes of the three
EAHEC strains were present stx2-phages showing an average sim-
ilarity with the Phi-191 of 90% and higher, indicating that the
three phages belonged to a homogeneous population. Conversely,
the contigs of the ETEC strain CB553/5 only mapped in a small
region of 7750 bp containing the genes encoding the Stx2, indicat-
ing that, in this strain the stx2-phage must be extensively different
from that present in the EAHEC strains.
The sequence of the phage the phage Phi-C125-06 corresponds
to the published sequence of phage TL-2011c, isolated from a
STEC O103:H25 during an outbreak of HUS cases occurred in
Norway in 2006 (Schimmer et al., 2008). We found that the
sequence of phage Phi-191 was about 90% homologous to that
of TL-2011c (data not shown), similarly to how reported for the
phage P13374, present in the EAHEC O104:H4 that caused the
German outbreak in 2011 (Beutin et al., 2012). Additionally, in
the Phi-C125-06 an IS 1203 was detected in the gene encoding
the B subunit of the Stx.
Finally, we observed that the contigs composing the WGS of
the strain ED 508 that mapped on the sequence of the phage Phi-
191 shared an average 65% of homology at nucleotide level.
Taken together these findings indicate that the stx2-phages
used in the infection experiments belonged to at least three
different types.
The PCR sub-typing scheme deployed by Scheutz and cowork-
ers was used to identify the subtypes of the Shiga toxin-coding
genes harbored by the stx2-phages used in this study (Scheutz
et al., 2012). All the phages harbored stx2a subtype, with the
exception of Phi-CB553/5, which possessed stx2d.
The insertion sites in the parental bacterial strains were deter-
mined for all the stx2-phages but the Phi-C125-06, which was
already described to be present in the wrbA locus (Sekse et al.,
2008a). With the exception of Phi-508, which is localized in yehV
locus, all the other phages composing the set used in this study
seemed to be inserted in wrbA.
The homogeneity of the phage suspensions used in the exper-
imental infections was determined by infecting the propagator K
12 strain LE 392 and by performing plaque lift and hybridiza-
tion with a probe corresponding to the stx2 gene encoding the
Stx2 A subunit. All the plaques present on the plates were positive
to hybridization with the stx2 probe, indicating that the all the
phage suspensions used in the following infection experiments
contained a unique bacteriophage population.
SUSCEPTIBILITY OF E. COLI STRAINS TO THE INFECTION WITH THE
stx2-PHAGES
E. coli strains belonging to all the known pathotypes were infected
with the set of six stx2-phages. The results of the spot agar
tests are reported in Table 1. In total, we assayed the suscepti-
bility of a panel of 35 E. coli strains, including five typical EPEC
(tEPEC, BfP-positive), five atypical EPEC (aEPEC, BfP-negative),
five ETEC, five EAggEC strains, three EIEC, five ExPEC, five
E. coli non-pathogenic strains belonging to the ECOR collection
(Ochman and Selander, 1984) and two E. coli K 12 laboratory
strains.
With the exception of the bacteriophage obtained from the
STEC/ETEC strain (CB553/5), which induced visible lysis in all
the strains infected, all the other phages were able to induce clear
lysis halos only in E. coli strains belonging to the Diarrheagenic
E. coli (DEC) pathogroups, although with different efficiency
(Table 1), but not in ExPEC cultures. Finally, the two E. coli K
12 strains used as controls demonstrated to be susceptible to
infection with all the phages tested, showing marked lytic areas.
These results suggested that the stx2-phages used in this study,
with the exception of the Phi-CB553/5, might have a specificity
for DEC.
To ascertain if the lack of lytic areas in the negative E. coli cul-
tures was due to mechanisms of resistance to infection, further
analyses were carried out aiming at determining the production of
Stx. Such an approach was based on the assumption that, for the
toxin to be produced, the phage DNA must be inserted into the
chromosome of the bacterial host and the host itself must there-
fore be susceptible to infection, also in the absence of visible lysis.
The occurrence of infection in the absence of lytic areas has been
previously reported during experimental infection of a panel of
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Table 1 | Results of the spot agar assays showing the susceptibility of the E. coli strains to infection with the different stx2-phages used.
Pathogroup (No. of strains) No. of strains showing lysis upon infection with Stx2-Phages
Phi-C125-06 Phi-703 Phi-191 Phi-508 Phi-924 Phi-CB553/5
EIEC (3) 1 3 3 3 2 3
ExPEC (5) 0 0 0 0 0 5
tEPEC (5) 0 1 1 0 1 5
aEPEC (5) 2 0 3 1 1 5
ETEC (5) 0 1 1 5 0 5
EAggEC (5) 1 0 2 1 1 5
ECOR collection (5) 1 3 4 2 2 5
E. coli K 12 (2) 2 2 2 2 2 2
Tot. (35) 7 10 16 14 9 35
diarrheagenic E. coli with a derivative chloramphenicol-resistant
stx2-phage (Schmidt et al., 1999).
All the bacterial strains used in the experimental infections
have been assayed for the capability to induce a cythopathic
effect (CPE) onto Vero cells monolayers before infection with the
stx2-phages and most of them proved negative by microscopic
observation of the cell up to 72 h post inoculum. Of the 35 E. coli
strains assayed two EXPEC, one tEPEC, two aEPEC, one EAggEC,
and four ETEC strains induced the death of Vero cells and have
therefore been excluded from the following screening by Vero cells
assay (VCA).
The bacterial strains that gave negative results in the VCA and
that, at the same time, did not show lysis in the spot agar assay,
were tested again after the experimental infection with the phages
by inoculating the supernatant of bacterial cultures obtained by
incubating in a liquid medium the area of the plates where the
phage suspension was applied on the test E. coli strains, onto Vero
cell monolayers.
By using this approach all the cultures showed a cytopathic
effect (CPE). The CPE observed appeared after 24 h incubation
and progressed toward the complete death of the monolayer in
48–72 h.
An alternative strategy was adopted to verify if the lack of lytic
areas in the test strains infected with phage Phi-C125-06 was due
tomechanisms of resistance. As amatter of fact, this phage doesn’t
possess an intact Stx2 B subunit-coding gene and therefore would
not induce any CPE on Vero cells monolayers. The bacterial cul-
tures derived by inoculating the area of the spot agar test where
the phage was applied were plated onto solid media and subjected
to colony blot using a probe corresponding to a region of the gene
encoding the Stx2 A subunit. None of the colonies were positive
in the hybridization experiments, suggesting that the strains had
not been infected.
VERIFICATION OF THE STABLE ACQUISITION OF stx2-PHAGES BY THE
E. COLI STRAINS
Following the observation that E. coli strains belonging to all the
pathogroups used were susceptible to infection with the stx2-
phages used, we investigated on the possibility that the E. coli
strains were able to maintain the phage DNA stably integrated
in their chromosome. Sub-cultures of the infected strains that
produced Stx were diluted and analyzed by colony blot to verify
the presence of the stx2 gene in their genome. Lysogens were only
observed in the cultures of one ETEC and one EAggEC strains as
well as in the E. coli K 12 strain LE 392 used as control, all infected
with the Phi 191 phage. The latter lysogen was stable and could be
cultured several times, while the cultures from the pathogenic E.
coli became negative already at the second cultural passages after
the phage infections.
DISCUSSION
STEC are human pathogens whose complex nature and
pathogenicity mechanisms are not completely understood yet. As
a matter of fact, a number of different geno-phenotypes have
been described so far in STEC strains isolated from human infec-
tions displaying a wide and diverse range of symptoms including
mild diarrheal disease as well as life threatening forms such as
the HUS (Tozzoli and Scheutz, 2014). The association between
the production of Stx and the ability to cause the A/E lesion, has
been long regarded as the virulence features asset characterizing
the STEC causing HUS (Levine, 1987), with the understood feel-
ing that the virulence gene repertoires described in other STEC
had to be associated with the less severe forms of the infection.
This approach led to the definition of schemes attempting at
categorizing STEC for the purpose of laying the ground for a
proper epidemiological approach and management of infections.
The most comprehensive among those schemes was developed by
Karmali and co-workers a decade ago (Karmali et al., 2003) and
considered either the clinical aspects of the infection or the viru-
lence features of the STEC strains. Such a scheme used the term
seropathotype (SPT) to define the different groups of STEC, with
the SPTs A and B including those causing the most severe forms
of infection or associated with outbreaks (Karmali et al., 2003).
Notably, the STEC included in the SPTs A and B are all capable to
cause the A/E lesion.
This reference scheme has been efficaciously used to frame the
STEC isolated from human disease for many years. Nevertheless,
in 2011, one of the largest and most severe outbreaks of STEC
infection occurred in Germany and France (Frank et al., 2011;
Mariani-Kurkdjian et al., 2011) and caused the paradigm to vault
in a new direction. The infecting strain, a STEC O104:H4 was
undoubtedly associated with HUS, with an impressive proportion
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of cases of infection progressing toward this severe syndrome
(Frank et al., 2011) and, at the same time, it was not able to induce
the A/E lesion (Bielaszewska et al., 2011).
The investigation on the genetic asset of the outbreak
strain revealed that beside the ability to produce Stx, it pos-
sessed the virulence genes encoding the adhesion machinery of
Enteroaggregative E. coli (EAggEC) (Bielaszewska et al., 2011)
and it has been proposed that this strain belongs to a new
pathogroup of E. coli termed Enteroaggeregative Haemorrhagic
E. coli (EAHEC) (Brzuszkiewicz et al., 2011). Several hypothesis
have been made on the evolution of the EAHECO104:H4 includ-
ing the opposite views of the derivation of this strain from an
EAggEC that acquired an stx2-phage by horizontal gene trans-
fer (Brzuszkiewicz et al., 2011; Rasko et al., 2011) or proposing
its evolution from an ancestor STEC O104:H4 by stepwise gain
and loss of chromosomal and plasmid-encoded virulence factors
(Mellmann et al., 2011). More recently evidences have been pro-
vided showing that the EAHEC O104:H4 could have evolved by
the uptake of a stx2-phage originated from the bovine reservoir by
an EAggEC O104:H4 (Beutin et al., 2013). This scenario parallels
what it can be inferred for the STEC strains causing the attach-
ing and effacing lesion, such as those belonging to SPTs A and B
(Karmali et al., 2003) which are also termed Enterohemorrhagic
E. coli (EHEC) (Levine, 1987). As a matter of fact, the latter can be
considered as atypical EPEC (aEPEC) that developed the capabil-
ity to produce Stx (Trabulsi et al., 2002). As in the case of EAggEC
and EAHEC, aEPEC and EHEC share the same mechanism of
colonization and are mainly distinguished by the capability to
produce Stx, which increase their pathogenicity.
The above considerations bring into question if STEC are
indeed an E. coli pathogroup in its own right, or rather if this
pathogen represents multiple pathogroups whose virulence has
been increased by the event of an stx-phage acquisition. Or even if
the phage itself might be considered as being the pathogen, using
the E. coli colonization machinery to establish a successful infec-
tion in the final host.Whatever scenario is chosen, it is undeniable
that for any intestinal infection to be successful, a pathogen must
efficiently colonize the mucosa, overcoming the competition with
the resident microflora. In this respect, both the SPTs A and B
STEC and EAHEC can rely on efficient colonization machiner-
ies, with the one present in the latter being recognized as causing
the most diffuse and long-lasting intestinal colonization (Nataro
and Kaper, 1998). Accordingly, while both the groups have been
associated with HUS, the EAHEC O104:H4 infections during the
German outbreak of 2011 progressed toward this severe form
in about 30% of cases (Frank et al., 2011), against the typical
5%–10% of cases of infection with SPT A and B STEC strains
developing HUS (Tarr et al., 2005).
How stated above admits the possibility that any E. coli strain
could acquire the ability to produce Stx and that, virtually any
pathogenic E. coli might stem a stable augmented-pathogenicity
variant threatening the public health systems. This is hold true for
EAggEC, which beside the German outbreak have been described
as being associated with HUS at least in other two outbreaks
occurred in the 90s in France (Morabito et al., 1998) and in
2013 in Italy (unpublished) as well as in some unrelated cases
recorded in Europe and Asia in the period 2000–2012 (Iyoda
et al., 2000; Scavia et al., 2011; Beutin et al., 2012; Dallman et al.,
2012).
In the conditions used in our laboratory we observed that,
beside the EAggEC, other E. coli pathogroups were susceptible
to infection with different stx2-phages obtained from a number
of different STEC types including EAHEC, typical STEC O157
and non-O157 as well as from an hybrid ETEC/STEC strain iso-
lated from a patient with diarrhea in Denmark (Dr. F. Scheutz,
personal communication). All the phages assayed conveyed the
genes encoding the Stx2 type (predominantly Stx2a subtype), the
one associated with STEC causing HUS and the only one found
in Stx-producing EAggEC so far.
We ascertained that in the conditions used in the laboratory,
all the DEC types assayed, including tEPEC, aEPEC, EAggEC,
ETEC, EIEC, were susceptible to infection with the stx2-phages.
Additionally, the stx2-phage from the hybrid ETEC/STEC strain
CB553/5 infected all the E. coli strains tested, including ExPEC,
and the field isolates of non-pathogenic E. coli of the ECOR
collection.
We observed that the stx2-phages used in this study seem not to
have specificity for particular E. coli groups although the efficacy
of the infections varied with the phage used (Table 1).
Our results are in line with the identification of the Stx2-
producing ETEC described above, and with the recent report of
a case of septicemia in a human patient with evidence of infec-
tion with an E. coli strain possessing the genes encoding the
Stx2 and matching the genetic background of an ExPEC (Wester
et al., 2013). Our results are also in agreement with how reported
in a previous study on the transduction of a chloramphenicol-
resistant stx2-phage where E. coli strains belonging to all the diar-
rheagenic E. coli groups were successfully infected and produced
stable lysogens (Schmidt et al., 1999). These findings provide evi-
dences that the stx2-phage acquisition can involve a spectrum of
E. coli hosts wider than expected and that no pathogroup-specific
barriers seem to exist to the acquisition of stx2-phages belonging
to the types used in this work.
However, it cannot be excluded that stx-phages different from
those used in this study might have a restricted host range and
that in the natural environment the spreading of the stx-phages
to E. coli hosts might be hindered by factors related with the bac-
terial hosts. The existence of such restrictions could explain how
reported in a recent study where the susceptibility of a panel of
31 EAggEC to infection with the stx2-phage derived from the
EAHEC O104:H4 that caused the German outbreak in 2011 was
assessed (Beutin et al., 2012). The authors observed that none of
the bacterial strains tested showed evidences of infection with the
stx2-phage in spite of the high titer used (Beutin et al., 2012).
Differences in the host range associated with the phage type
could be also hypothesized by considering the results of the spot
agar tests performed in this study. As a matter of fact, we observed
that while the phage Phi-CB553/5 induced clear lysis in all the
strains analyzed, all the other phages infected a variable number
of strains in each of the pathogroups but never induced lysis in the
ExPEC strains analyzed. Nevertheless we could observe that such
strains induced CPE onto Vero cells monolayers after the infection
with the stx2-phages. This observation, although not confirmed
by sero-neutralization, suggests a wider host range of the phages
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used in this study. Further work is needed to clarify the mecha-
nisms leading to the selection of the stx-phages able to infect the
different E. coli pathogroups.
Interestingly, all the E. coli pathotypes, with the exception of
typical STEC, have a human reservoir and an inter-human trans-
mission cycle (Nataro and Kaper, 1998), while the typical STEC
and the related stx-phages seem to have their reservoir in the
intestinal tract of ruminants (Caprioli et al., 2005; Beutin et al.,
2013). This observation implies that for the event of an stx-phage
acquisition by a human E. coli to occur a common ecosystemmust
exist where the two organisms may encounter and interact. Such
an ecosystem could be represented by the intestine of a mam-
malian host or the environment (Schmidt et al., 1999; Sekse et al.,
2008b; Imamovic et al., 2009; Dopfer et al., 2010). Given the inter-
human circulation of the EAggEC, the possibility that EAHEC
may have arisen following an environmentally mediated event of
an stx2-phage acquisition is interesting. As a matter of fact in low-
income countries, where infections with DEC are endemic the
ineffective treatments of human sewages may account for a wide
dispersion of these pathogens in the environment, with the con-
sequent possibility for them to come into contact with stx-phages
originating from ruminant’s excreta. Accordingly, an origin in
these countries has been traced or postulated for some of the Stx2-
producing EAggEC (Scavia et al., 2011; Beutin et al., 2012; Weiser
et al., 2013), strengthening such a hypothesis for their derivation.
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